New category of immunotherapies, called checkpoint inhibitors, appears safe to use in patients with both advanced malignancies and HIV.
08 Nov 2017 8:12 AM
US regulators approved drug cocktail in May but limited clinical trial data means questions remains whether it will retain effectiveness.
08 Sep 2017 8:30 AM
Despite success, drugs watchdog Nice has ruled the treatment as not cost effective.
26 Jun 2017 1:52 PM
Patients with non-small-cell lung cancer survived for 13.8 months on average on the drug called atezolizumab
13 Dec 2016 9:47 AM